经验证的患者报告结局指标与中轴型脊柱关节炎患者自报疾病状态的相关性
该回顾性分析纳入557例中轴型脊柱关节炎患者的3120次就诊,评估ASDAS、BASDAI、ASAS20、ASAS40及ASAS部分缓解与患者自报疾病状态(分为很好、轻度、重度、极重度)的关联。多数就诊中ASDAS和BASDAI能较好反映患者自报状态,而其他临床试验用指标在较大比例就诊中未能捕捉患者自报疾病状态。
要点
- ASDAS和BASDAI在多数就诊中能较好反映患者自报疾病状态。
- ASAS20、ASAS40及ASAS部分缓解在较大比例就诊中未能捕捉患者自报疾病状态。
- 自报状态为很好或轻度者在ASDAS不活动/low就诊中分别占98.7%和90.9%。
核心结论
- 多数临床就诊中,患者自报疾病状态可被ASDAS和BASDAI较好地捕捉。
- 其他研究所用临床试验指标在较大比例就诊中未能捕捉患者自报疾病状态。
研究设计与样本
- 回顾性分析557例中轴型脊柱关节炎患者初次及最后五次就诊的数据。
- 每次就诊评估ASDAS、BASDAI、ASAS20、ASAS40及ASAS部分缓解。
- 患者自报疾病状态按症状负担严重程度分为很好(状态满意)、轻度、重度、极重度。
- 采用混合模型分析上述患者报告结局指标与患者自报疾病状态的关联。
- 中位随访4.7年,共分析3120次就诊。
主要发现
- ASDAS不活动就诊中自报状态为很好或轻度者占98.7%,ASDAS低活动就诊中占90.9%。
- ASDAS高活动就诊中自报状态为很好或轻度者占67.9%,ASDAS极高活动就诊中占39.3%。
- 达到ASAS20的就诊中自报状态为重度或极重度者占15.1%,未达到ASAS20者占26.0%。
- 达到ASAS40的就诊中自报状态为重度或极重度者占7.2%,未达到ASAS40者占25.1%。
- 达到ASAS部分缓解的就诊中自报状态为重度或极重度者占0.6%,未达到者占30.1%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In axSpA, validated PROs are well-established in clinical trials, but it remains unclear whether they comprehensively reflect patients' discomfort and disease status. We aimed to investigate how patients' self-reported disease status compares with validated clinical trial measures during routine clinical visits. METHODS: Data from axSpA patients' initial and last five visits were retrospectively analysed. ASDAS, BASDAI, ASAS20, ASAS40 and ASAS partial remission were assessed at each visit and compared with patients' self-reported disease status, categorized into very good (status satisfaction), mild, severe and very severe based on patients' self-reported opinion on the level of severity of symptom burden related to axSpA. The association of these PROs with patients' self-reported disease status was analysed using mixed models. RESULTS: A total of 3,120 visits over a median follow-up of 4.7 years from 557 axSpA patients were analyzed. Very good or mild self-reported disease status was reported in 98.7% of visits with inactive and 90.9% of visits with low ASDAS compared to 67.9% with high and 39.3% with very high ASDAS. Severe or very severe self-reported disease status was reported in 15.1% of visits with ASAS20 achievement, in 7.2% with ASAS40 achievement, and in 0.6% with achievement of ASAS partial remission, compared with 26.0% without ASAS20 achievement, 25.1% without ASAS40 achievement, and 30.1% without achievement of ASAS partial remission. CONCLUSIONS: Patients' self-reported disease status was well captured by ASDAS and BASDAI in most clinical visits. Other investigated measures used in clinical trials failed to capture patients' self-reported disease status in a large proportion of visits.
引用
- Redeker I, Tsiami S, Klavdianou K, et al. Association of validated patient reported outcome measures with patients' self-reported disease status in axial spondyloarthritis. Rheumatology (Oxford). 2025. PMID: 39656966. doi:10.1093/rheumatology/keae648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。